Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$112.64
-0.4%		$108.02
$43.07
▼
$118.63
$5.61B1.041.51 million shs1.63 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$221.72
-0.5%		$182.49
$22.28
▼
$254.48
$88.52B1.0919.59 million shs9.00 million shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
0.00%+3.94%+4.34%+11.06%+123.54%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%+10.80%+17.35%+304.45%+797.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$112.64
-0.4%		$108.02
$43.07
▼
$118.63
$5.61B1.041.51 million shs1.63 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$221.72
-0.5%		$182.49
$22.28
▼
$254.48
$88.52B1.0919.59 million shs9.00 million shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
0.00%+3.94%+4.34%+11.06%+123.54%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%+10.80%+17.35%+304.45%+797.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
2.25
Hold$95.47-15.25% Downside
Moderna, Inc. stock logo
MRNA
Moderna
2.08
Hold$107.10-51.70% Downside

Current Analyst Ratings Breakdown

Latest CAKE and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/29/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
William Blair logo
William Blair
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingOutperform
10/28/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$116.00
10/28/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
10/28/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Freedom Capital logo
Freedom Capital
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold ➝ Strong-Buy
10/28/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$128.00 ➝ $127.00
10/28/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Stephens logo
Stephens
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingEqual Weight$100.00
10/27/2026
Moderna, Inc. stock logo
MRNA
Moderna
William Blair logo
William Blair
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeOutperform ➝ Market Perform
10/26/2026
Moderna, Inc. stock logo
MRNA
Moderna
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingOverweight$167.00 ➝ $230.00
10/23/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetSell$60.00 ➝ $80.00
10/23/2026
Moderna, Inc. stock logo
MRNA
Moderna
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell
10/23/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$93.00 ➝ $110.00
(Data available from 11/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$3.75B1.49$5.86 per share19.23$8.76 per share12.86
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B45.53N/AN/A$22.14 per share10.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$148.43M$4.2226.6921.961.625.20%46.95%6.74%N/A
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/6/2026 (Estimated)

Latest CAKE and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2026Q3 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$1.10N/AN/AN/A$890.25 millionN/A
10/27/2026Q3 2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$0.9610$1.02+$0.0590$1.19$1.01 billion$1.03 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$1.201.07%+24.57%28.44%N/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest CAKE and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/21/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
quarterly$0.301.11%11/10/202611/10/202611/24/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
1.08
0.59
0.52
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
94.48%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
8.00%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
48,40049.76 million45.78 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Moderna, Inc. $MRNA Shares Sold by Profund Advisors LLC
November 1 at 6:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-shares-sold-by-profund-advisors-llc-2026-11-01/
Moderna, Inc. $MRNA Shares Newly Bought by Americana Partners LLC
November 1 at 3:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-shares-newly-bought-by-americana-partners-llc-2026-11-01/
How Investors Are Reacting To Moderna Stock Phase 3 Melanoma Vaccine Data
October 31 at 5:59 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/investors-reacting-moderna-stock-phase-091453633.html
Moderna, Inc. $MRNA Stock: Oppenheimer & Co. Inc. Raises Position
October 31 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-stock-oppenheimer-co-inc-raises-position-2026-10-31/
Moderna (NASDAQ:MRNA) and Oramed Pharmaceuticals (NASDAQ:ORMP) Financial Contrast
October 31 at 2:31 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31169260
Moderna mRNA cancer result vs BioNTech oncology pipeline
October 30 at 2:56 PM  |  msn.comhttps://www.msn.com/en-us/news/other/moderna-mrna-cancer-result-vs-biontech-oncology-pipeline/vi-AA2e0AwT
Assessing Merck and Moderna’s mRNA cancer vaccine
October 30 at 2:56 PM  |  statnews.comS
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
October 30 at 2:56 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/earnings-preview-moderna-mrna-q3-130006796.html
Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up
October 30 at 11:06 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/30/regeneron-surges-12-as-sanofi-dupixent-windfall-and-eylea-hd-power-earnings-beat-moderna-slides-2-merck-edges-higher-pfizer-ticks-up/?utm_source=snapi
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
October 30 at 11:01 AM  |  zacks.comhttps://www.zacks.com/stock/news/3019691/earnings-preview-moderna-mrna-q3-earnings-expected-to-decline?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_9-3019691
North Dakota State Investment Board Sells 27,663 Shares of Moderna, Inc. $MRNA
October 30 at 5:51 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-north-dakota-state-investment-board-sells-27663-shares-of-moderna-inc-mrna-2026-10-30/
Moderna, Inc. $MRNA Stock: China Universal Asset Management Co. Ltd. Increases Stake
October 30 at 4:00 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-stock-china-universal-asset-management-co-ltd-increases-stake-2026-10-30/
Moderna, Inc. $MRNA Stock Holdings Boosted by D.A. Davidson & CO.
October 30 at 3:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moderna-inc-mrna-stock-holdings-boosted-by-da-davidson-co-2026-10-30/
Moderna (MRNA) Projected to Announce Quarterly Earnings on Friday
October 30 at 1:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31166599
Moderna (MRNA) Set to Post Quarterly Earnings on Friday
October 30 at 1:10 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/upcoming-moderna-mrna-set-to-post-quarterly-earnings-on-friday-2026-10-30/
Moderna (NASDAQ:MRNA) Shares Up 4% - Here's What Happened
October 29 at 5:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-shares-up-4-heres-what-happened-2026-10-29/
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?
October 29 at 1:26 PM  |  zacks.comhttps://www.zacks.com/stock/news/3018949/gsk-vs-moderna-which-large-cap-biotech-stock-offers-more-growth?cid=cs-stocknewsapi-ft-analyst_blog|most_popular_stocks-3018949
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
October 29 at 1:15 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/investors-heavily-search-moderna-inc-120002269.html
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?
October 29 at 1:15 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-vs-moderna-large-cap-152300531.html
Top Biotech Stocks To Follow Today - October 29th
October 29 at 1:00 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-top-biotech-stocks-to-follow-today-october-29th-2026-10-29/
Moderna Bought Time Not Earnings
October 29 at 10:11 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4959204-moderna-bought-time-not-earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Illuminated Nike swoosh logo on a wall above a display pedestal with sneakers in a retail store.
Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
By Thomas Hughes | October 4, 2026
Kalshi and Polymarket logos beside a smartphone showing a prediction market on the Chiefs winning the Super Bowl, with a football in the background.
Want Private-Market Access to Kalshi and Polymarket? Try This ETF
By Jessica Mitacek | October 8, 2026
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
White Tesla sports car parked at a launch site with rocket boosters visible against a sunset sky.
Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
By Sam Quirke | October 19, 2026
Vaccine vial and syringe on a lab surface with DNA strands and virus particle illustrations in the background.
Merck and Moderna's Cancer Vaccine Worked—Who Gets Paid?
By Chris Markoch | October 27, 2026
Cheesecake Factory stock logo

Cheesecake Factory NASDAQ:CAKE

$112.64 -0.48 (-0.42%)
Closing price 10/30/2026 04:00 PM Eastern
Extended Trading
$113.66 +1.02 (+0.91%)
As of 10/30/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Cheesecake Factory Incorporated operates and licenses restaurants in the United States and Canada. The company operates bakeries that produce cheesecakes and other baked products for its restaurants, international licensees, third-party bakery customers, external foodservice operators, retailers, and distributors. It operates restaurants under the brands comprising The Cheesecake Factory, North Italia, Flower Child, Fox Restaurant Concepts. The Cheesecake Factory Incorporated was founded in 1972 and is headquartered in Calabasas, California.

Moderna stock logo

Moderna NASDAQ:MRNA

$221.72 -1.04 (-0.47%)
Closing price 10/30/2026 04:00 PM Eastern
Extended Trading
$221.40 -0.32 (-0.14%)
As of 10/30/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas